Gallic Acid Derivatives Propyl Gallate and Epigallocatechin Gallate Reduce rRNA Transcription via Induction of KDM2A Activation

We previously reported that lysine-demethylase 2A (KDM2A), a Jumonji-C histone demethylase, is activated by gallic acid to reduce H3K36me2 levels in the rRNA gene promoter and consequently inhibit rRNA transcription and cell proliferation in the breast cancer cell line MCF-7. Gallic acid activates A...

Full description

Bibliographic Details
Main Authors: Yuji Tanaka, Makoto Tsuneoka
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/12/1/30
_version_ 1827666398079352832
author Yuji Tanaka
Makoto Tsuneoka
author_facet Yuji Tanaka
Makoto Tsuneoka
author_sort Yuji Tanaka
collection DOAJ
description We previously reported that lysine-demethylase 2A (KDM2A), a Jumonji-C histone demethylase, is activated by gallic acid to reduce H3K36me2 levels in the rRNA gene promoter and consequently inhibit rRNA transcription and cell proliferation in the breast cancer cell line MCF-7. Gallic acid activates AMP-activated protein kinase (AMPK) and increases reactive oxygen species (ROS) production to activate KDM2A. Esters of gallic acid, propyl gallate (PG) and epigallocatechin gallate (EGCG), and other chemicals, reduce cancer cell proliferation. However, whether these compounds activate KDM2A has yet to be tested. In this study, we found that PG and EGCG decreased rRNA transcription and cell proliferation through KDM2A in MCF-7 cells. The activation of both AMPK and ROS production by PG or EGCG was required to activate KDM2A. Of note, while the elevation of ROS production by PG or EGCG was limited in time, it was sufficient to activate KDM2A. Importantly, the inhibition of rRNA transcription and cell proliferation by gallic acid, PG, or EGCG was specifically observed in MCF-7 cells, whereas it was not observed in non-tumorigenic MCF10A cells. Altogether, these results suggest that the derivatization of gallic acid may be used to obtain new compounds with anti-cancer activity.
first_indexed 2024-03-10T01:51:10Z
format Article
id doaj.art-8ab21f0d15c64c7a9851767affde5396
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T01:51:10Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-8ab21f0d15c64c7a9851767affde53962023-11-23T13:05:55ZengMDPI AGBiomolecules2218-273X2021-12-011213010.3390/biom12010030Gallic Acid Derivatives Propyl Gallate and Epigallocatechin Gallate Reduce rRNA Transcription via Induction of KDM2A ActivationYuji Tanaka0Makoto Tsuneoka1Laboratory of Molecular and Cellular Biology, Faculty of Pharmacy, Takasaki University of Health and Welfare, Takasaki 370-0033, JapanLaboratory of Molecular and Cellular Biology, Faculty of Pharmacy, Takasaki University of Health and Welfare, Takasaki 370-0033, JapanWe previously reported that lysine-demethylase 2A (KDM2A), a Jumonji-C histone demethylase, is activated by gallic acid to reduce H3K36me2 levels in the rRNA gene promoter and consequently inhibit rRNA transcription and cell proliferation in the breast cancer cell line MCF-7. Gallic acid activates AMP-activated protein kinase (AMPK) and increases reactive oxygen species (ROS) production to activate KDM2A. Esters of gallic acid, propyl gallate (PG) and epigallocatechin gallate (EGCG), and other chemicals, reduce cancer cell proliferation. However, whether these compounds activate KDM2A has yet to be tested. In this study, we found that PG and EGCG decreased rRNA transcription and cell proliferation through KDM2A in MCF-7 cells. The activation of both AMPK and ROS production by PG or EGCG was required to activate KDM2A. Of note, while the elevation of ROS production by PG or EGCG was limited in time, it was sufficient to activate KDM2A. Importantly, the inhibition of rRNA transcription and cell proliferation by gallic acid, PG, or EGCG was specifically observed in MCF-7 cells, whereas it was not observed in non-tumorigenic MCF10A cells. Altogether, these results suggest that the derivatization of gallic acid may be used to obtain new compounds with anti-cancer activity.https://www.mdpi.com/2218-273X/12/1/30rRNA transcriptionbreast cancerKDM2Agallic acidpropyl gallateepigallocatechin gallate
spellingShingle Yuji Tanaka
Makoto Tsuneoka
Gallic Acid Derivatives Propyl Gallate and Epigallocatechin Gallate Reduce rRNA Transcription via Induction of KDM2A Activation
Biomolecules
rRNA transcription
breast cancer
KDM2A
gallic acid
propyl gallate
epigallocatechin gallate
title Gallic Acid Derivatives Propyl Gallate and Epigallocatechin Gallate Reduce rRNA Transcription via Induction of KDM2A Activation
title_full Gallic Acid Derivatives Propyl Gallate and Epigallocatechin Gallate Reduce rRNA Transcription via Induction of KDM2A Activation
title_fullStr Gallic Acid Derivatives Propyl Gallate and Epigallocatechin Gallate Reduce rRNA Transcription via Induction of KDM2A Activation
title_full_unstemmed Gallic Acid Derivatives Propyl Gallate and Epigallocatechin Gallate Reduce rRNA Transcription via Induction of KDM2A Activation
title_short Gallic Acid Derivatives Propyl Gallate and Epigallocatechin Gallate Reduce rRNA Transcription via Induction of KDM2A Activation
title_sort gallic acid derivatives propyl gallate and epigallocatechin gallate reduce rrna transcription via induction of kdm2a activation
topic rRNA transcription
breast cancer
KDM2A
gallic acid
propyl gallate
epigallocatechin gallate
url https://www.mdpi.com/2218-273X/12/1/30
work_keys_str_mv AT yujitanaka gallicacidderivativespropylgallateandepigallocatechingallatereducerrnatranscriptionviainductionofkdm2aactivation
AT makototsuneoka gallicacidderivativespropylgallateandepigallocatechingallatereducerrnatranscriptionviainductionofkdm2aactivation